To leverage scientific advancements in creating autologous biologic preparations, which enable physicians to optimize the practice of regenerative medicine.

Learn About Greyledge Technologies


Our Services

We have created a technology platform that allows physicians the opportunity to integrate autologous PRP (Platelet-rich Plasma) and BMCC (Bone Marrow Cell Concentrate) biologic preparations into their practice.

Learn More

Our Process

The use of a patient’s own biologic preparation complements the natural healing process present in patients but is dependent on a variety of components.

Learn More

Our Applications

Numerous reports on potential applications for PRP and BMCC suggest that autologous PRP and BMCC preparations are considered to support a patient’s natural healing processes.

Learn More

Meet The Executive Team

Dr. David Karli

David C. Karli, MD MBA

Founder and Chief Executive Officer

Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.

Mark D. Kitchen

Mark D. Kitchen

Director of Operations

Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.

Tim W. Lynch, BA Health Sciences 

Director of Training and Development

In his position as Director of Training & Development, his duties include all aspects of laboratory operations, training and providing other support to maintain Greyledge’s commitment to quality. Tim is a key element in the development and launch of new Laboratories.

Recent News

Read More
Contact Us